• NEW
    Tech Launch Perspective
    Aug. 04, 2026

    SAP’s financial management product announcements at SAP Sapphire 2026 reinforce its vision for autonomous finance as part of its broader Autonomous Enterprise strategy through enhancements spanning agent-led finance execution, continuous and intelligent finance operations, enterprise AI…
  • NEW
    Blog
    Aug. 03, 2026

    In Part 1 of this series, Why the Migration Clock Has Already Started, we explained why Banking, Financial Services and Insurance (BFSI) enterprises cannot wait for a formal mandate to begin their Post-quantum Cryptography (PQC) migration and estimated a roughly US$7 billion spending opportunity across the top…
  • See Us At
    July 21, 2026

    Join Sanket Anshuman, Practice Director at Everest Group, to explore how pharmacovigilance (PV) is evolving from a compliance-driven function to an AI-enabled, intelligence-led safety model. Discover how organizations can leverage AI, automation, and real-world data to…
  • Blog
    July 21, 2026

    Current state of cryptography in BFSI  Banks, insurers, and capital markets enterprises have been using cryptography for a long time across every important part of their business. It protects everything from mobile payments to complex trading platforms and third-party connections.  …
  • Viewpoint
    June 29, 2026

    The post-approval phase represents one of the most complex and strategically critical stages in the life sciences product life cycle, requiring enterprises to ensure continuous safety monitoring, regulatory compliance, and real-world performance optimization. With increasing diverse…
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Roundtable
    April 16, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Thursday, May 07, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Roundtable
    March 31, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Tuesday, April 14, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • Market Insights™
    Nov. 05, 2025

  • In 2006, I visited my first captive center in Bengaluru. At the time, the model was still in its formative years – many multinational organizations were only beginning to explore the potential of setting up their own in-house centers…
  • Blog
    Nov. 02, 2025

    The clinical outsourcing market is undergoing a transition with the emergence of specialist-focused Clinical Research Organizations (CROs). A specialist CRO concentrates its expertise in a defined area, such as a therapeutic focus, trial phase or technology, or geographic niche, rather than offering broad,…
  • Provider Compendium
    Oct. 24, 2025

    Everest Group’s Procure-to-Pay (P2P) Products – Provider Compendium 2025 provides comprehensive and fact-based snapshots of nine P2P products and includes insights on the global P2P products market. It examines each product’s features, enhancements, and market adoption…
  • State of the Market
    Oct. 01, 2025

    The surge in case volumes, more stringent regulatory demands, and therapeutic areas’ rising complexities are significantly transforming pharmacovigilance (PV). As the industry adapts to more tailored reporting requirements and longer patient monitoring periods, enterprises are under…
  • Provider Compendium
    Sep. 30, 2025

    Everest Group’s Supply Chain Management (SCM) BPS – Provider Compendium 2025 provides comprehensive and fact-based snapshots of 11 SCM service providers and includes insights into the global SCM service provider landscape. It offers detailed profiles of…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Provider Compendium
    Sep. 16, 2025

    Pharmacovigilance (PV) operations have become a strategic priority for life sciences enterprises facing heightened regulatory scrutiny, evolving safety standards, and growing complexity across global markets. This report provides an in-depth assessment of 12 leading PV service…
  • PEAK Matrix®
    Sep. 12, 2025

    Enterprises are recalibrating procurement and finance operations as cost pressures, regulatory complexity, and rapid technology advancements intensify. Procure-to-Pay (P2P) products have become integral to unifying purchasing and Accounts Payable (AP) workflows, enabling organizations to automate processes,…
  • PEAK Matrix®
    Aug. 08, 2025

    Global disruptions and fast-paced innovations continue to impact and reshape enterprise supply chains. In this evolving landscape, Supply Chain Management (SCM) BPS providers are central in establishing resilience and driving transformation in enterprises. These providers streamline…

Items per page